ZTEK

Zentek

ZTEK

Market cap $106M

Overview Fund Activity

1.01 USD

-0.03

2.88%

At close Updated Sep 12, 4:00 PM EDT

Pre-market

After hours

1.03

+0.02

1.98%

1 day

-2.88%

5 days

21.98%

1 month

15.43%

3 months

-32.21%

6 months

12.22%

Year to date

3.15%

1 year

14.64%

5 years

-62.87%

10 years

-62.87%

About: Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.

Employees: 18

Healthcare Medical Instruments & Supplies

0

Funds holding %

of 7,462 funds

–

Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

6% more capital invested

Capital invested by funds: $1.72M [Q1] → $1.83M (+$107K) [Q2]

5% more funds holding

Funds holding: 21 [Q1] → 22 (+1) [Q2]

0.16% more ownership

Funds ownership: 1.47% [Q1] → 1.63% (+0.16%) [Q2]

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

See Fund Rankings

Financial journalist opinion

Based on 6 articles about ZTEK published over the past 30 days

Zentek Announces New Board Nominees

GUELPH, ON / ACCESS Newswire / September 10, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company, today announces that, further to its news release on September 3, 2025, it is updating the slate of director nominees for the upcoming annual general and special meeting to be held on September 25, 2025 (the "Meeting").

Zentek Announces New Board Nominees

Zentek Announces Resignation of CEO - Greg Fenton to take New Strategic Leadership Role in U.S.-Based Venture

GUELPH, ON / ACCESS Newswire / September 3, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company, today announces that Greg Fenton has resigned as Chief Executive Officer ("CEO") and as a member of the Board of Directors, effective immediately, to become the full-time CEO of Altek Advanced Materials Inc. ("Altek"), a Nevada incorporated private company focused on the commercialization of advanced material technologies in the United States, of which Greg Fenton owns more than a 50% beneficial equity interest.

Zentek Announces Resignation of CEO - Greg Fenton to take New Strategic Leadership Role in U.S.-Based Venture

Zentek Announces Changes to Board of Directors and Changes to Board Nominations for Upcoming Annual and Special Meeting of Shareholders

GUELPH, ON / ACCESS Newswire / September 3, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN) an intellectual property technology development and commercialization company, today announces that Ilse Treurnicht has resigned from the Board of Directors effective immediately.

Zentek Announces Changes to Board of Directors and Changes to Board Nominations for Upcoming Annual and Special Meeting of Shareholders

Zentek Subsidiary Albany Graphite Corp. Awarded $500,000 Critical Minerals Innovation Fund Grant for Purification and Anode Development Project

GUELPH, ONTARIO / ACCESS Newswire / September 2, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company, is pleased to announce that its wholly owned subsidiary, Albany Graphite Corp. ("AGC") has been awarded a grant of $500,000 from the Ontario Government's Critical Minerals Innovation Fund ("CMIF") for its Albany Graphite Purification and Anode Material Development Project.

Zentek Subsidiary Albany Graphite Corp. Awarded $500,000 Critical Minerals Innovation Fund Grant for Purification and Anode Development Project

Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Guelph, Ontario--(Newsfile Corp. - August 27, 2025) - Zentek Ltd. (Nasdaq: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company") announces that on August 26, 2025, it received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of the Company's common shares ("Shares") has been below US $1.00 per share for 31 consecutive business days.

Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Top 3 Health Care Stocks You'll Regret Missing This Quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 3 Health Care Stocks You'll Regret Missing This Quarter

Zentek Announces Management Transition

GUELPH, ON / ACCESS Newswire / July 11, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company, announces that the board of directors has determined not to extend the consulting contract for Greg Fenton, the Company's Chief Executive Officer and a Director of the Company, when the term expires on March 31, 2026.

Zentek Announces Management Transition

Zentek Provides Regulatory Update on ZenGUARD(TM) Enhanced Air Filters

GUELPH, ON / ACCESS Newswire / June 26, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company, reports that it has received a letter from Health Canada noting that Health Canada is considering the classification of ZenGUARD™ Enhanced Air Filters and inviting Zentek to submit additional information regarding appropriate regulatory classification.

Zentek Provides Regulatory Update on ZenGUARD(TM) Enhanced Air Filters

Zentek Announces Test Results Validating ZenGUARD(TM) Enhanced Air Filters as a High-Performance Solution for ASHRAE Standard 241 Compliance

GUELPH, ON / ACCESS Newswire / June 12, 2025 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company, is pleased to announce new independent test results comparing the viral filtration efficiency ("VFE") of ZenGUARD™ Enhanced Air Filters against the bacteriophage MS2 compared to equivalent Minimum Efficiency Reporting Value ("MERV")-rated filters without ZenGUARD™.

Zentek Announces Test Results Validating ZenGUARD(TM) Enhanced Air Filters as a High-Performance Solution for ASHRAE Standard 241 Compliance

Zentek Announces Agreement with RSK Environment Limited to Expand International Reach of ZenGUARD(TM) Enhanced Air Filters

GUELPH, ON / ACCESS Newswire / May 27, 2025 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces the execution of an agency agreement with RSK Environment Ltd.

Zentek Announces Agreement with RSK Environment Limited to Expand International Reach of ZenGUARD(TM) Enhanced Air Filters

See News Rankings

Charts implemented using Lightweight Charts™